Posttranslational protein modifications - Current implications for cancer detection, prevention, and therapeutics

被引：173

作者：

Krueger, Karl E. ^{[1
]}

Srivastava, Sudhir ^{[1
]}

机构：

[1] NCI, Canc Biomarkers Res Grp, Div Canc Prevent, NIH, Bethesda, MD 20892 USA

来源：

MOLECULAR & CELLULAR PROTEOMICS | 2006年 / 5卷 / 10期

关键词：

D O I：

10.1074/mcp.R600009-MCP200

中图分类号：

Q5 [生物化学];

学科分类号：

071010 ; 081704 ;

摘要：

[No abstract available]

引用

页码：1799 / 1810

页数：12

共 75 条

[1]

Baker GL, 2005, CELL CYCLE, V4, P330

[2] On ubiquitin ligases and cancer [J].

Beckmann, JS ;

Maurer, F ;

Delorenzi, M ;

Falquet, L .

HUMAN MUTATION, 2005, 25 (06) :507-512

[3] Modifications of H3 and H4 during chromatin replication, nucleosome assembly, and histone exchange [J].

Benson, LJ ;

Gu, YL ;

Yakovleva, T ;

Tong, K ;

Barrows, C ;

Strack, CL ;

Cook, RG ;

Mizzen, CA ;

Annunziato, AT .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (14) :9287-9296

[4] Printed covalent glycan array for ligand profiling of diverse glycan binding proteins [J].

Blixt, O ;

Head, S ;

Mondala, T ;

Scanlan, C ;

Huflejt, ME ;

Alvarez, R ;

Bryan, MC ;

Fazio, F ;

Calarese, D ;

Stevens, J ;

Razi, N ;

Stevens, DJ ;

Skehel, JJ ;

van Die, I ;

Burton, DR ;

Wilson, IA ;

Cummings, R ;

Bovin, N ;

Wong, CH ;

Paulson, JC .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (49) :17033-17038

[5] Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans [J].

Block, TM ;

Comunale, MA ;

Lowman, M ;

Steel, LF ;

Romano, PR ;

Fimmel, C ;

Tennant, BC ;

London, WT ;

Evans, AA ;

Blumberg, BS ;

Dwek, RA ;

Mattu, TS ;

Mehta, AS .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (03) :779-784

[6] Post-translational modification of p53 in tumorigenesis [J].

Bode, AM ;

Dong, ZG .

NATURE REVIEWS CANCER, 2004, 4 (10) :793-805

[7] Monoclonal and bispecific antibodies as novel therapeutics [J].

Booy, EP ;

Johar, D ;

Maddika, S ;

Pirzada, H ;

Sahib, MM ;

Gehrke, I ;

Loewen, S ;

Louis, SF ;

Kadkhoda, K ;

Mowat, M ;

Los, M .

ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2006, 54 (02) :85-101

[8] The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin [J].

Butler, LM ;

Zhou, XB ;

Xu, WS ;

Scher, HI ;

Rifkind, RA ;

Marks, PA ;

Richon, VM .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (18) :11700-11705

[9] Tumor-specific exon 1 mutations could be the 'hit event' predisposing Rb2/p130 gene to epigenetic silencing in lung cancer [J].

Caterina, C ;

Marcella, M ;

Giordano, A .

ONCOGENE, 2005, 24 (38) :5821-5826

[10] Hyperphosphorylation of pRb: a mechanism for RB tumour suppressor pathway inactivation in bladder cancer [J].

Chatterjee, SJ ;

George, B ;

Goebell, PJ ;

Alavi-Tafreshi, M ;

Shi, SR ;

Fung, YK ;

Jones, PA ;

Cordon-Cardo, C ;

Datar, RH ;

Cote, RJ .

JOURNAL OF PATHOLOGY, 2004, 203 (03) :762-770

← 1 2 3 4 5 6 7 8 →